UBS Upgrades Celestica to Buy, Raises Price Target to $430

Benzinga Newsdesk www.benzinga.com Positive 91.2%

Neg 0% Neu 0% Pos 91.2%

UBS analyst David Vogt upgrades Celestica (NYSE:CLS) from Neutral to Buy and raises the price target from $410 to $430.

Comments

No comments yet. Be the first!